Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma 5 Neoplasms 3 Multiple Myeloma 3 COVID-19 3 Opioid-Related Disorders 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Sezary Syndrome 1 Recurrence 1 Obesity 1 Neurologic Manifestations 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Hematologic Neoplasms 1 Genital Neoplasms, Female 1 Dementia 1 Criminal Behavior 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Breast Neoplasms 1 Anomia 1 Alzheimer Disease 1

Interventions

Peripheral Blood Stem Cell Transplantation 39 fludarabine phosphate 36 Cyclophosphamide 31 Mycophenolic Acid 28 Cyclosporine 25 Whole-Body Irradiation 24 Tacrolimus 22 Busulfan 18 Antilymphocyte Serum 18 Radiotherapy 16 Methotrexate 16 Flow Cytometry 14 Filgrastim 14 Etoposide 13 Methylprednisolone 10 Lenalidomide 10 Bortezomib 10 Vorinostat 9 Melphalan 9 mogamulizumab 8 Therapeutics 8 Rituximab 8 Psychiatric Rehabilitation 8 Polymerase Chain Reaction 8 Gemcitabine 8 Cord Blood Stem Cell Transplantation 7 Bexarotene 7 pembrolizumab 6 Alemtuzumab 6 tanespimycin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sezary Syndrome × Standard of Care × Lymphoid × Clear all

NCT05206045 2022-01-25

SURPASSe

Assistance Publique - Hôpitaux de Paris

Sezary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡